enVVeno Medical
NVNO
7 hedge funds and large institutions have $397K invested in enVVeno Medical in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
305% more capital invested
Capital invested by funds: $98K → $397K (+$299K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
17% more funds holding
Funds holding: 6 → 7 (+1)
0.05% more ownership
Funds ownership: 0% → 0.05% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$231K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.5K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.86K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$931 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$56K |
| 2 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
-$17K |
| 3 |
LPL Financial
San Diego,
California
|
-$11K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8K |
NVNO Hedge Fund Activity: Q4 2020 in Review
7 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2020, worth a combined $397K — up 305% from $98K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NVNO positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $231K. The largest seller was Citadel Advisors, exiting entirely with an estimated $56K sold.
- 7 institutional investors held enVVeno Medical (NVNO) as of Q4 2020, up from 6 in Q3 2020.
- Funds reported $397K of enVVeno Medical stock for Q4 2020, up 305% quarter-over-quarter.
- 5 funds opened new enVVeno Medical positions in Q4 2020 and 4 closed out, a net change of +1 holder.
- The largest enVVeno Medical buyer in Q4 2020 was Virtu Financial, an estimated $231K added.
- The largest enVVeno Medical seller in Q4 2020 was Citadel Advisors, an estimated $56K sold.
Based on aggregated 13F filings for Q4 2020.